NEXI — Neximmune Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: NexImmune Reports Q4 And Full Year 2021 Financial Results
Brief: Neximmune Inc Files For Mixed Shelf Of Upto $200 Million - SEC Filing
Brief: NexImmune Appoints Kristi Jones As Chief Executive Officer And Member Of The Board Of Directors
Brief: Neximmune Announces Research Collaboration With Rutgers, The State University Of New Jersey
Brief: Neximmune Announces Formation Of Autoimmune And Infectious Diseases Scientific Advisory Board
Brief: Neximmune Announces Preliminary Phase 1/2 Nexi-002 Results In Patients With Multiple Myeloma
Neximmune Inc reports results for the quarter ended in September - Earnings Summary
Brief: Neximmune Reports Third Quarter 2021 Financial Results And Provides Business Updates
Neximmune Inc expected to post a loss of 64 cents a share - Earnings Preview
Brief: Neximmune To Explore The Use Of Aim™ Direct Injection Technology In Type 1 Diabetes
Neximmune Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Neximmune Posts Q1 Loss Per Share Of $0.71
Brief: Neximmune Reports Fiscal Year 2020 Financial Results And Recent Updates
Brief: Rapha Capital Management Announces Successful Initial Public Offering Of Portfolio Company Neximmune Inc
U.S. STOCKS ON THE MOVE-Bumble, HubSpot, Amicus, NexImmune
NexImmune: Jumps in Nasdaq debut
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Neximmune Announces Pricing Of Upsized IPO
Live Markets: Bumble generates buzz as IPO pace set to stumble